- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02611011
Assessing the Usability and Clinical Utility of the Congo Red Dot Test: A Survey
December 31, 2018 updated by: Gynuity Health Projects
To determine if women can understand the instructions, carry out the test, and interpret the test results.
Women will be recruited to complete a test instruction and comprehension assessment and a usability assessment.
Study Overview
Detailed Description
To determine if women can understand the instructions, carry out the test, and interpret the test results.
Women will be recruited to complete a test instruction and comprehension assessment and a usability assessment.
Study participants will be a convenience sample of women seeking health services.
Participants will first be asked to review the instructions for the Congo Red Dot Test and complete a short written questionnaire that assesses their comprehension of the test instructions.
Participants will then be asked to perform the test using a test control and to interpret the results obtained by answering a second written questionnaire.
After the woman performs the test, a healthcare provider will use a matched control to perform a second test.
Study Type
Observational
Enrollment (Actual)
198
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Mexico City, Mexico
- Centro de Slaud Beatriz Velasco de Aleman
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
10 years to 50 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Women attending Centre de Salud Beatriz Velasco de Aleman for health services
Description
Inclusion Criteria:
- Eligible to consent for research
- Able to read Spanish well enough to read the test instructions
- Able to give informed consent
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Women
Women seeking health services will perform the Congo Red Dot test (GV-005) individually by following the the test instructions
|
The GV-005 is a simple test has been developed to detect unfolded or misfolded proteins in urine.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
CRD Test Comprehension
Time Frame: within 5 minutes of reading test instructions
|
proportion of women who demonstrated various levels of understanding of the instructions for the CRD Test
|
within 5 minutes of reading test instructions
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
CRD Test Usability
Time Frame: within 5 minutes of performing test
|
the proportion of women able to correctly use the CRD test
|
within 5 minutes of performing test
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2018
Primary Completion (Actual)
June 30, 2018
Study Completion (Actual)
December 30, 2018
Study Registration Dates
First Submitted
November 18, 2015
First Submitted That Met QC Criteria
November 18, 2015
First Posted (Estimate)
November 20, 2015
Study Record Updates
Last Update Posted (Actual)
January 3, 2019
Last Update Submitted That Met QC Criteria
December 31, 2018
Last Verified
December 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 4005B
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Preeclampsia
-
Comanche BiopharmaRecruitingPreeclampsia | Preterm Preeclampsia | sFlt1 Mediated Preterm PreeclampsiaAustralia
-
MemorialCare Health SystemActive, not recruitingPreeclampsia | Preeclampsia Postpartum | Preeclampsia Severe | Preeclampsia MildUnited States
-
Christiana Care Health ServicesTerminatedPre-Eclampsia | Preeclampsia | Preterm | Preeclampsia Severe | Preeclampsia Second Trimester | Preeclampsia Complicating Childbirth | Preeclampsia PuerperiumUnited States
-
University Medical Centre LjubljanaCompletedPreeclampsia Postpartum | Preeclampsia SevereSlovenia
-
Anna Stanhewicz, PhDActive, not recruiting
-
Cedars-Sinai Medical CenterThermoFisher Scientific Brahms Biomarkers FranceCompletedGestational Hypertension | Preeclampsia Severe | Preeclampsia and Eclampsia | Chronic Hypertension in Obstetric Context | Superimposed Pre-Eclampsia | Preeclampsia MildUnited States
-
Saint Thomas Hospital, PanamaRecruitingPreeclampsia | Severe PreeclampsiaPanama
-
Alexander HarrisonNot yet recruitingPreeclampsia Postpartum | Preeclampsia SevereUnited States
-
Washington University School of MedicineCompletedPreeclampsia Postpartum | Preeclampsia SevereUnited States
Clinical Trials on Congo Red Test (GV-005)
-
Gynuity Health ProjectsInternational Centre for Diarrhoeal Disease Research, BangladeshCompletedPreeclampsiaBangladesh, Mexico
-
Gynuity Health ProjectsNationwide Children's HospitalCompletedPreeclampsiaBangladesh, Mexico
-
Gynuity Health ProjectsNationwide Children's HospitalUnknownPreeclampsiaBangladesh, Mexico
-
Oncology Institute of Southern SwitzerlandUniversity of Kiel; Ente Ospedaliero Cantonale, BellinzonaCompleted
-
Cerus CorporationCompletedFocus:Use of S303 RBCs in Patients With Acute AnemiaGermany
-
Malaysia Palm Oil BoardUniversiti Putra Malaysia; International Medical UniversityCompleted
-
Atlas UniversityCompleted
-
Angel Augusto Perez CalatayudGrupo Mexicano para el Estudio de la Medicina IntensivaCompletedPost Partum Hemorrhage | Transfusion Related Complication | Fibrinogenolysis; Hemorrhage | Fibrinogen; Deficiency, Acquired | Massive HemorrhageMexico
-
Vanderbilt UniversityNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...CompletedPostural Orthostatic Tachycardia SyndromeUnited States
-
University of AarhusThe Ministry of Science, Technology and Innovation, Denmark; European Regional...Completed